Journal article

Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome


Authors listKlemm, Philipp; Mueller-Ladner, Ulf; Tarner, Ingo H.; Lange, Uwe; Hudowenz, Ole

Publication year2020

JournalAutoimmunity Reviews

Volume number19

Issue number8

ISSN1568-9972

eISSN1873-0183

DOI Linkhttps://doi.org/10.1016/j.autrev.2020.102594

PublisherElsevier



Citation Styles

Harvard Citation styleKlemm, P., Mueller-Ladner, U., Tarner, I., Lange, U. and Hudowenz, O. (2020) Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome, Autoimmunity Reviews, 19(8), Article 102594. https://doi.org/10.1016/j.autrev.2020.102594

APA Citation styleKlemm, P., Mueller-Ladner, U., Tarner, I., Lange, U., & Hudowenz, O. (2020). Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome. Autoimmunity Reviews. 19(8), Article 102594. https://doi.org/10.1016/j.autrev.2020.102594


Last updated on 2025-02-04 at 00:43